Naghibi, Hamid
Janssen, Dennis
van den Boogaard, Ton
van Tienen, Tony
Verdonschot, Nico
Funding for this research was provided by:
University of Twente
Article History
Received: 13 May 2019
Accepted: 12 March 2020
First Online: 11 April 2020
Compliance with ethical standards
:
: Dr. Van Tienen is the head of stock options of ATRO Medical Company. The meniscus prosthesis studied in this study was provided by this company. The other authors declare no other potential conflict of interest.